Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

  • Home
  • Audit Findings
    • General Audit Findings in Clinical Trials
    • Investigator Site-Level Audit Findings
    • Sponsor & CRO-Level Audit Findings
    • Trial Master File (TMF) & eTMF Audit Findings
    • Informed Consent Audit Findings
    • Safety Reporting Audit Findings
    • Data Integrity & EDC Audit Findings
    • GCP Training & Compliance Audit Findings
    • Clinical Trial Supply & IMP Audit Findings
    • Ethics Committee / IRB Audit Findings
    • CAPA & Inspection Readiness Audit Findings
    • Case Studies & Trends in Audit Findings
  • Audits, CAPA & Deviations
    • CRO Audit Oversight
    • CAPA Management in CROs
    • Deviation Handling in CROs
    • Inspection Readiness for CROs
    • Data Integrity & Systems Oversight
    • Training & Quality Culture in CROs
  • SOPs for GCP
    • Global SOPs (Applicable to all Agencies)
    • SOP for IDE/Device
    • FDA — Unique SOPs (United States)
    • EMA — Unique SOPs (European Union)
    • CDSCO/DCGI – Unique SOPs (India)
    • WHO – Unique SOPs
    • ICH – Unique SOPs
    • MHRA — Unique SOPs (United Kingdom)
    • Health Canada — Unique SOPs (Canada)
    • PMDA — Unique SOPs
    • TGA — Unique SOPs
    • NMPA — Unique SOPs
    • ANVISA — Unique SOPs
    • Swiss Medic — Unique SOPs
    • Medsafe/HDEC — Unique SOPs (New Zealand)
  • US Regulatory Submissions
  • Toggle search form

SOP for Clinical Trial Data Management and Integrity

Posted on September 9, 2025 digi By digi

SOP for Clinical Trial Data Management and Integrity

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clinical-trial-data-management-and-integrity”
},
“@id”: “https://www.clinicalstudies.in/clinical-trial-data-management-and-integrity”,
“headline”: “SOP for Clinical Trial Data Management and Integrity”,
“name”: “SOP for Clinical Trial Data Management and Integrity”,
“description”: “Detailed SOP describing sponsor, investigator, and CRO responsibilities for clinical trial data management and integrity in New Zealand, ensuring compliance with Medsafe, HDEC, and ICH GCP requirements.”,
“keywords”: “Data management SOP NZ, SOP for clinical trial data management NZ, SOP for EDC compliance NZ, SOP for CRF handling NZ, SOP for database lock NZ, SOP for query management NZ, SOP for source data verification NZ, SOP for PI data responsibilities NZ, SOP for sponsor data oversight NZ, SOP for CRO data management NZ, SOP for HDEC data requirements NZ, SOP for Medsafe data compliance, SOP for trial data integrity NZ, SOP for GCP compliance data management NZ, SOP for inspection readiness data NZ, SOP for data cleaning NZ, SOP for database validation NZ, SOP for data privacy NZ, SOP for archiving trial data NZ,

SOP for audit trail compliance NZ, SOP for electronic records NZ, SOP for data confidentiality NZ, SOP for trial subject protection data NZ, SOP for CAPA in data findings NZ, SOP for quality assurance data NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

See also  SOP for Right-to-Try/Expanded Access Coordination (When Applicable)

Published on 21/12/2025

Clinical Trial Data Management and Integrity SOP

Department Clinical Research
SOP No. CS/NZ-DM/210/2025
Supersedes N.A.
Page No. 1 of 26
Issue Date 28/08/2025
Effective Date 05/09/2025
Review Date 05/09/2027

Table of Contents

Toggle
  • Purpose
  • Scope
  • Responsibilities
  • Accountability
  • Procedure
  • Abbreviations
  • Documents
  • References
  • Approval
  • Annexures
  • Revision History

Purpose

The purpose of this SOP is to define standardized processes for managing and safeguarding clinical trial data in New Zealand. It ensures integrity, accuracy, and confidentiality of data in compliance with Medsafe, HDEC, and ICH GCP requirements.

Scope

This SOP applies to all sponsor-led and investigator-initiated trials in New Zealand. It covers Case Report Form (CRF) handling, data entry, query resolution, database validation, database lock, audit trails, and archiving. It applies to sponsors, investigators, CROs, data managers, and QA teams.

Responsibilities

  • Sponsor: Establishes data management plan, ensures secure EDC systems, and oversees CRO activities.
  • Principal Investigator (PI): Ensures accuracy of site-level data entry and resolution of queries.
  • Clinical Research Coordinator (CRC): Assists in timely data entry and source verification.
  • Data Manager: Oversees data validation, query generation, and database lock.
  • CRO: Provides data management services when delegated by sponsor.
  • Quality Assurance (QA): Audits data management processes and ensures CAPA implementation.

Accountability

The sponsor’s Head of Data Management is accountable for data management compliance. The PI is accountable for site-level data accuracy and completeness.

See also  SOP for TMF Setup (Paper/eTMF) and Structure

Procedure

1. Data Management Plan (DMP)

  1. Prepare and approve a DMP covering CRF handling, query management, database validation, and archiving.
  2. Maintain DMP in Trial Master File (TMF).

2. CRF Handling and Data Entry

  1. Ensure CRFs are completed promptly and accurately.
  2. Electronic CRFs (eCRFs) must be entered into EDC within 5 working days of subject visit.
  3. Maintain CRF Completion Log (Annexure-1).

3. Query Management

  1. Data managers issue queries for discrepancies.
  2. Investigators resolve queries within 10 working days.
  3. Maintain Query Resolution Log (Annexure-2).

4. Database Validation and Lock

  1. Perform system validation checks prior to database lock.
  2. Document lock approval in Database Lock Log (Annexure-3).

5. Data Privacy and Security

  1. Ensure compliance with Privacy Act 2020.
  2. De-identify subject data before analysis.
  3. Maintain access control for EDC systems.

6. Archiving

  1. Archive data management documentation in TMF and ISF for at least 10 years post-trial.
  2. Ensure audit trails remain accessible for regulatory inspections.

Abbreviations

  • CRF: Case Report Form
  • eCRF: Electronic Case Report Form
  • PI: Principal Investigator
  • CRC: Clinical Research Coordinator
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • DMP: Data Management Plan
  • TMF: Trial Master File
  • ISF: Investigator Site File
  • CAPA: Corrective and Preventive Action
  • EDC: Electronic Data Capture
  • GCP: Good Clinical Practice
  • HDEC: Health and Disability Ethics Committees
See also  SOP for Data Migration and Archiving of eClinical Systems

Documents

  1. CRF Completion Log (Annexure-1)
  2. Query Resolution Log (Annexure-2)
  3. Database Lock Log (Annexure-3)

References

  • Medsafe — Medicines and Medical Devices Safety Authority
  • HDEC — Health and Disability Ethics Committees
  • ICH E6(R2) Good Clinical Practice
  • New Zealand Privacy Act 2020
  • WHO Clinical Trial Standards

Version: 1.0

Approval

Prepared By Checked By Approved By
Name: Rajesh Kumar
Date: 20/08/2025
Signature: __________
Name: Sunita Reddy
Date: 22/08/2025
Signature: __________
Name: Dr. Meera Iyer
Date: 28/08/2025
Signature: __________

Annexures

Annexure-1: CRF Completion Log

Date Subject ID Visit Completed By Checked By
10/08/2025 NZ-801 Visit 1 CRC: Anjali Rao PI: Dr. Anita Patel

Annexure-2: Query Resolution Log

Date Query ID Query Description Resolution Resolved By
15/08/2025 QRY-2101 Missing AE date Date corrected Dr. Anita Patel

Annexure-3: Database Lock Log

Date Database Name Status Approved By
25/08/2025 NZ-2025-DB Locked Head of Data Management

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
28/08/2025 1.0 Initial SOP for clinical trial data management and integrity in New Zealand. New SOP created for Medsafe, HDEC, Privacy Act 2020, and GCP compliance. Head of Clinical Research

For more SOPs visit: Pharma SOP.

Medsafe/HDEC — Unique SOPs (New Zealand), SOP for GCP Tags:Data management SOP NZ, SOP for archiving trial data NZ, SOP for audit trail compliance NZ, SOP for CAPA in data findings NZ, SOP for clinical trial data management NZ, SOP for CRF handling NZ, SOP for CRO data management NZ, SOP for data cleaning NZ, SOP for data confidentiality NZ, SOP for data privacy NZ, SOP for database lock NZ, SOP for database validation NZ, SOP for EDC compliance NZ, SOP for electronic records NZ, SOP for GCP compliance data management NZ, SOP for HDEC data requirements NZ, SOP for inspection readiness data NZ, SOP for Medsafe data compliance, SOP for PI data responsibilities NZ, SOP for quality assurance data NZ, SOP for query management NZ, SOP for source data verification NZ, SOP for sponsor data oversight NZ, SOP for trial data integrity NZ, SOP for trial subject protection data NZ

Post navigation

Previous Post: Pre-Visit Checklists for Remote Monitoring with Risk-Based Oversight Strategies
Next Post: SOP for Follow-Up and Closure of Monitoring Findings

Quick Guide – 1

  • Clinical Trial Phases (7)
    • Preclinical Studies (25)
    • Phase 0 (Microdosing Studies) (6)
    • Phase 1 (Safety and Dosage) (66)
    • Phase 2 (Efficacy and Side Effects) (54)
    • Phase 3 (Confirmation and Monitoring) (70)
    • Phase 4 (Post-Marketing Surveillance) (79)
  • Regulatory Guidelines (71)
    • U.S. FDA Regulations (14)
    • CDSCO (India) Guidelines (11)
    • EMA (European Medicines Agency) Guidelines (17)
    • PMDA (Japan) Guidelines (1)
    • MHRA (UK) Guidelines (1)
    • TGA (Australia) Guidelines (1)
    • Health Canada Guidelines (1)
    • WHO Guidelines (1)
    • ICH Guidelines (12)
    • ASEAN Guidelines (11)
  • Country-Specific Clinical Trials (254)
    • Clinical Trials in USA (51)
    • Clinical Trials in China (49)
    • Clinical Trials in EU (51)
    • Clinical Trials in India (51)
    • Clinical Trials in UK (51)
    • Clinical Trials in Canada (1)
  • Clinical Trial Design and Protocol Development (106)
    • Randomized Controlled Trials (RCTs) (11)
    • Adaptive Trial Designs (10)
    • Crossover Trials (10)
    • Parallel Group Designs (11)
    • Factorial Designs (11)
    • Cluster Randomized Trials (11)
    • Single-Arm Trials (10)
    • Open-Label Studies (11)
    • Blinded Studies (Single, Double, Triple) (11)
    • Non-Inferiority and Equivalence Trials (8)
    • Randomization Techniques in Crossover Trials (1)
  • Good Clinical Practice (GCP) and Compliance (78)
    • GCP Training Programs (11)
    • ICH-GCP Compliance (11)
    • GCP Violations and Audit Responses (11)
    • Monitoring Plans (11)
    • Investigator Responsibilities (11)
    • Sponsor Responsibilities (11)
    • Ethics Committee Roles (11)
  • Clinical Research Operations (44)
    • Study Start-Up Activities (9)
    • Site Selection and Initiation (10)
    • Patient Enrollment Strategies (13)
    • Data Collection and Management (10)
    • Monitoring and Auditing (1)
    • Study Close-Out Procedures (0)
  • Site Management and Monitoring (72)
    • Site Feasibility Assessments (20)
    • Site Initiation Visits (10)
    • Routine Monitoring Visits (10)
    • Source Data Verification (12)
    • Site Close-Out Visits (10)
    • Site Performance Metrics (10)
  • Contract Research Organizations (CROs) (55)
    • Full-Service CROs (11)
    • Functional Service Providers (FSPs) (10)
    • Niche/Specialty CROs (11)
    • CRO Selection Criteria (11)
    • CRO Oversight and Management (11)
  • Patient Recruitment and Retention (57)
    • Recruitment Strategies (11)
    • Retention Strategies (11)
    • Patient Engagement Tools (11)
    • Diversity and Inclusion in Trials (11)
    • Use of Social Media for Recruitment (12)
  • Informed Consent and Ethics Committees (54)
    • Informed Consent Process (11)
    • Ethics Committee Submissions (10)
    • Ethical Considerations in Vulnerable Populations (11)
    • Consent in Emergency Research (10)
    • Re-Consent Procedures (11)
  • Decentralized Clinical Trials (DCTs) (55)
    • Remote Patient Monitoring (10)
    • Telemedicine in Trials (11)
    • Home Health Visits (11)
    • Direct-to-Patient Drug Delivery (11)
    • Digital Consent Platforms (11)
  • Clinical Trial Supply and Logistics (55)
    • Investigational Product Management (11)
    • Cold Chain Logistics (10)
    • Supply Chain Risk Management (11)
    • Labeling and Packaging (11)
    • Return and Destruction of Supplies (11)
  • Safety Reporting and Pharmacovigilance (56)
    • Adverse Event Reporting (11)
    • Serious Adverse Event (SAE) Management (11)
    • Safety Signal Detection (11)
    • Risk Management Plans (11)
    • Periodic Safety Update Reports (PSURs) (11)
  • Clinical Data Management (57)
    • Case Report Form (CRF) Design (11)
    • Data Entry and Validation (11)
    • Query Management (11)
    • Database Lock Procedures (11)
    • Data Archiving (12)
  • Biostatistics in Clinical Research (57)
    • Statistical Analysis Plans (11)
    • Sample Size Determination (11)
    • Interim Analysis (11)
    • Survival Analysis (12)
    • Handling Missing Data (11)
  • Real-World Evidence (RWE) and Observational Studies (56)
    • Registry Studies (11)
    • Retrospective Chart Reviews (11)
    • Prospective Cohort Studies (11)
    • Case-Control Studies (11)
    • Use of Electronic Health Records (EHRs) (11)
  • Medical Writing and Study Documentation (58)
    • Protocol Writing (11)
    • Investigator Brochures (11)
    • Clinical Study Reports (CSRs) (11)
    • Manuscript Preparation (11)
    • Regulatory Submission Documents (13)
  • Trial Master File (TMF) Management (57)
    • TMF Structure and Contents (10)
    • Electronic TMF Systems (7)
    • TMF Quality Control (12)
    • Inspection Readiness (12)
    • Archiving Requirements (11)
  • Protocol Amendments and Version Control (45)
    • Amendment Classification (11)
    • Regulatory Submissions of Amendments (11)
    • Communication of Changes to Sites (11)
    • Version Control Systems (11)
  • Data Integrity and ALCOA+ Principles (46)
    • Attributable, Legible, Contemporaneous, Original, Accurate (ALCOA) (12)
    • Complete, Consistent, Enduring, and Available (ALCOA+) (10)
    • Data Governance Policies (12)
    • Audit Trails (11)
  • Investigator and Site Training (44)
    • Investigator Meetings (11)
    • Site Staff Training Programs (11)
    • Training Documentation (11)
    • Continuing Education Requirements (10)
  • Budgeting and Financial Management (40)
    • Budget Development (10)
    • Site Payment Management (10)
    • Financial Forecasting (10)
    • Cost Tracking and Reporting (10)
  • AI, Big Data, and Technology in Clinical Trials (41)
    • AI in Patient Recruitment (10)
    • Machine Learning for Data Analysis (10)
    • Blockchain for Data Security (10)
    • Wearable Devices and Sensors (11)
  • Career in Clinical Research (52)
    • Clinical Research Coordinator (CRC) Roles (11)
    • Clinical Research Associate (CRA) Roles (10)
    • Data Manager Careers (10)
    • Biostatistician Roles (10)
    • Regulatory Affairs Careers (11)
  • Clinical Trial Registries and Result Disclosure (40)
    • ClinicalTrials.gov Registration (9)
    • EudraCT Registration (10)
    • Results Posting Requirements (10)
    • Transparency Initiatives (11)

Quick Guide – 2

  • Clinical Trial Operations & Data Integrity (31)
    • TMF & eTMF (10)
    • Study Operations & Enrollment (10)
    • Biostats, CDISC & Traceability (11)
  • Clinical Trial Operations & Compliance (54)
    • Clinical Trial Logistics (30)
    • TMF / eTMF Management (6)
    • Clinical Trial Phases & Design (6)
    • Regulatory Submissions (CTD/eCTD) (6)
    • Vendor Oversight & CRO Compliance (6)
  • Quality Assurance and Audit Management (40)
    • Internal Audits (10)
    • External Audits (10)
    • Audit Preparation (10)
    • Corrective and Preventive Actions (CAPA) (10)
  • Risk-Based Monitoring (RBM) (40)
    • Risk Assessment Tools (10)
    • Centralized Monitoring Techniques (10)
    • Key Risk Indicators (KRIs) (10)
    • Key Risk Indicators (KRIs) (10)
  • Standard Operating Procedures (SOPs) (39)
    • SOP Development (9)
    • SOP Training (10)
    • SOP Compliance Monitoring (10)
    • SOP Revision Processes (10)
  • Electronic Data Capture (EDC) and eCRFs (40)
    • EDC System Selection (10)
    • eCRF Design (10)
    • Data Validation Rules (10)
    • User Access Management (10)
  • Wearables and Digital Endpoints (35)
    • Integration of Wearable Devices (10)
    • Digital Biomarkers (9)
    • Data Collection and Analysis (7)
    • Regulatory Considerations (9)
  • Blockchain and Data Security in Trials (39)
    • Blockchain Applications in Clinical Research (10)
    • Data Encryption Methods (9)
    • Access Control Mechanisms (11)
    • Compliance with Data Protection Regulations (9)
  • Biomarkers and Companion Diagnostics (39)
    • Biomarker Identification (10)
    • Validation Processes (10)
    • Companion Diagnostic Development (9)
    • Regulatory Approval Pathways (10)
  • Pediatric and Geriatric Clinical Trials (55)
    • Ethical Considerations (11)
    • Age-Specific Protocol Design (22)
    • Dosing and Safety Assessments (11)
    • Recruitment Strategies (11)
  • Oncology Clinical Trials (54)
    • Phase-Specific Oncology Trials (10)
    • Immunotherapy Studies (14)
    • Biomarker-Driven Trials (10)
    • Basket and Umbrella Trials (8)
    • Cancer Vaccines (12)
  • Vaccine Clinical Trials (40)
    • Phase I–IV Vaccine Trials (10)
    • Immunogenicity Assessments (10)
    • Cold Chain Requirements (10)
    • Post-Marketing Surveillance (10)
  • Rare and Orphan Disease Trials (186)
    • Patient Recruitment Challenges (31)
    • Regulatory Incentives (10)
    • Adaptive Trial Designs (10)
    • Natural History Studies (10)
    • Regulatory Frameworks (22)
    • Trial Design & Methodology (22)
    • Operational Challenges (21)
    • Ethics & Patient Engagement (20)
    • Data & Technology (20)
    • Case Studies & Breakthroughs (20)
  • Bioavailability and Bioequivalence Studies (BA/BE) (41)
    • Study Design Considerations (11)
    • Analytical Method Validation (10)
    • Statistical Analysis Requirements (10)
    • Regulatory Submission (10)
  • Regulatory Submissions and Approvals (73)
    • IND (Investigational New Drug) Submissions (10)
    • CTA (Clinical Trial Application) (10)
    • NDA/BLA/MAA Filings (10)
    • ANDA for Generics (10)
    • eCTD Submission Process (2)
    • Pre-Submission Meetings (FDA Type A/B/C) (10)
    • Regulatory Query Response Handling (10)
    • Post-Approval Commitments (11)
  • Clinical Trial Transparency and Ethics (60)
    • Trial Disclosure Obligations (10)
    • Result Publication Requirements (10)
    • Ethical Review Standards (10)
    • Open Access Data Sharing (10)
    • Informed Consent Disclosure (10)
    • Ethical Dilemmas in Global Research (10)
  • Protocol Deviation and CAPA Management (50)
    • Major vs Minor Deviations (10)
    • Root Cause Analysis (9)
    • CAPA Documentation (9)
    • Preventive Action Planning (1)
    • Monitoring and Training Based on Deviations (10)
    • Deviation Logs and Tracking Tools (11)
  • Audit Trails and Inspection Readiness (59)
    • TMF and eTMF Audit Trails (10)
    • Audit Trail Reviews in EDC (10)
    • Inspection Preparation Checklists (10)
    • Regulatory Inspection Types (Routine, For-Cause) (10)
    • Responding to Audit Observations (9)
    • Mock Inspections and Readiness Drills (10)
  • Study Feasibility and Site Selection (68)
    • Feasibility Questionnaire Design (10)
    • Site Capability Assessment (11)
    • Historical Performance Review (17)
    • Geographic and Demographic Considerations (10)
    • PI (Principal Investigator) Experience Evaluation (10)
    • Site Activation Planning (10)
  • Outsourcing and Vendor Management (65)
    • Vendor Qualification Process (12)
    • Due Diligence and Risk Assessment (11)
    • Vendor Contract Management (12)
    • KPIs for Vendor Performance (10)
    • Vendor Oversight and Audits (10)
    • Communication and Escalation Plans (10)
  • Remote Monitoring and Virtual Visits (64)
    • Centralized Monitoring Techniques (12)
    • Source Data Review Remotely (12)
    • Virtual Site Visits Protocols (11)
    • eConsent and Remote Data Collection (10)
    • Hybrid Monitoring Models (10)
    • Remote Site Training (9)
  • Laboratory and Sample Management (77)
    • Sample Collection SOPs (10)
    • Sample Labeling and Transport (10)
    • Chain of Custody Documentation (11)
    • Bioanalytical Testing and Storage (15)
    • Central vs Local Labs (11)
    • Laboratory Data Reconciliation (20)
  • Adverse Event Reporting and Management (63)
    • AE vs SAE Differentiation (10)
    • Expedited Reporting Timelines (11)
    • MedDRA Coding of Events (11)
    • AE Data Collection in eCRFs (11)
    • Causality and Severity Assessments (10)
    • Regulatory Reporting Requirements (CIOMS, SUSARs) (10)
  • Interim Analysis and Trial Termination (60)
    • Data Monitoring Committees (DMC) (10)
    • Pre-Specified Stopping Rules (10)
    • Statistical Thresholds for Early Stopping (10)
    • Adaptive Modifications Based on Interim Data (10)
    • Unblinding Protocols (10)
    • Reporting of Early Termination to Regulators (10)

Recent Posts

  • Test
  • Comprehensive Guide to Dental Health Care with Braces
  • Understanding Dental Health Care: Managing Implants Cost Effectively
  • Invisalign Alternatives: Practical Dental Health Care Solutions
  • Practical Guide to Dental Health Care: Managing Braces Effectively

Copyright © 2026 Clinical Research Made Simple.

Powered by PressBook WordPress theme